PubMed · 3928824
Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion.
Abstract
Sodium valproate (VPA), a branched short-chain fatty acid, always causes a hyperammonemia of renal origin in fasting man. The intake of medium-length, straight-chain fatty acids abolishes the VPA-induced hyperammonemia, and VPA free fraction increases concomitantly. Accordingly, fatty acids could be useful in preventing and treating hyperammonemia-accompanied stuporous states which are complications of VPA medication.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J M Warter, C Marescaux, E Hirsch, L Rumbach, G Micheletti, G Chabrier, M Imler. 1985. Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion.. https://doi.org/10.1016/0022-510x(85)90140-6. https://searchpubmed.org/record/pubmed%3A3928824/decrease-of-valproate-induced-hyperammonemia-in-normal-subjects-by-lipid-ingestion
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.